3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
134
Breast Neoplasms
91
Neoplasms
8
Breast Neoplasms, Male
6
Neoplasm Metastasis
5
Advanced Breast Cancer
4
Salivary Gland Neoplasms
3
Prostate Adenocarcinoma
3
Triple Negative Breast Neoplasms
2
Recurrence
2
Osteoporosis
2
Leiomyoma
2
Infertility
2
Advanced Prostate Cancer
2
Stage I Prostate Adenocarcinoma AJCC v7
1
Sexual Dysfunctions, Psychological
1
Sexual Dysfunction, Physiological
1
Radiation Injuries
1
Primary Ovarian Insufficiency
1
Primary Dysautonomias
1
Patients With T1-4 Advanced Prostate Cancer
1
PSA Level Greater Than Two
1
Ovarian Neoplasms
1
Osteitis Deformans
1
Myofibroma
1
Lymphatic Metastasis
1
Kidney Diseases
1
Inflammatory Breast Neoplasms
1
Hypertension
1
Hyperlipidemias
1
Interventions
vistusertib
1
ribociclib
1
Tamoxifen
1
Letrozole
1
Goserelin
1
Fulvestrant
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Advanced Metastatic Breast Cancer
×
Goserelin
×
Clear all
NCT02278120
2024-03-12
MONALEESA-7
Novartis
Phase 3
Completed
672 enrolled
16 charts
1 FDA